Alluvi tirzepatide has been emerged as a promising therapeutic option for get more info the treatment of metabolic disorders. This preclinical evaluation assessed the efficacy and safety of tirzepatide 40mg in in vivo models of metabolic syndrome. The studies demonstrated that tirzepatide 40mg substantially enhanced glycemic regulation and reduced